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Original Article

Female Genital Tuberculosis in Pakistan – A Retrospective
Review of 10‑Year Laboratory Data and Analysis of 32 Cases
Tazeen Fatima, Rumina Hasan, Faisal Riaz Malik, Imran Ahmed, Linda Alice Bartlett1, Michael G. Gravett2, Sadia Shakoor
Department of Pathology & Laboratory Medicine, Aga Khan University, Karachi, Pakistan, 1Bloomberg School of Public Health, Johns Hopkins School of Public
Health, Baltimore, MD, 2Department of Obstetrics and Gynecology, University of Seattle, WA, USA

Abstract
Background: Female genital tuberculosis (FGTB) is an underobserved clinical entity owing to diagnostic challenges stemming from difficulty
of obtaining diagnostic specimens and paucibacillary nature of the disease. Yet, FGTB is a cause of infertility, pelvic pain, or menstrual
irregularities in high‑burden countries. To assess laboratory and microbiology diagnostic utilization for FGTB in Pakistan, we have collected
data from 2007 to 2016 to inform the need for improved laboratory diagnostics. The objectives of this study were to determine the proportion
of FGTB as culture‑confirmed extrapulmonary tuberculosis (EPTB) and to describe the characteristics of women with culture‑confirmed
FGTB in a nationwide laboratory network in Pakistan. Method: A retrospective database was established by accessing laboratory archives
and analyzed by sex and source to determine extrapulmonary cases among women. Data were checked for quality, and after removing patient
identifiers and duplicate samples, frequencies were calculated in MS Excel. Clinical characteristics of patients were derived from a linked hospital
database for those patients who were diagnosed and managed at the affiliated university hospital in Karachi, Pakistan. Results: Over 10 years,
410,748 mycobacterial cultures were received from multiple geographic sites throughout Pakistan and processed at the study laboratory. The
overall mean culture positivity rate was 5.9% ± 3.5%, while the mean culture positivity rate among females was 2.8% ± 0.8%. Among female
culture‑confirmed tuberculosis cases, the pulmonary‑to‑EPTB ratio of infection was 5. Over 10 years, a total of 32 FGTB cases were reported
on the basis of positive cultures for Mycobacterium tuberculosis; 3 (9.4%) were rifampin resistant. Conclusions: FGTB currently constitutes a
small but significant proportion of culture‑confirmed EPTB. A fewer number of laboratory requisitions suggest the need to increase awareness
and testing. The advent of high‑sensitivity molecular testing on extrapulmonary specimens has the potential to improve diagnostic accuracy
and improved detection of FGTB cases in high‑burden regions.
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Introduction
Female genital tuberculosis (FGTB) classically presents
with infertility, pelvic pain, or menstrual irregularities, with
or without other systemic symptoms of tuberculosis.[1] Such
symptoms and resulting debilitation as well as economic
costs can have serious detrimental effects on women’s quality
of life, sexual and reproductive health, mental health, and
productivity. Yet, the burden of FGTB is unclear – remaining an
underdiagnosed form of extrapulmonary tuberculosis (EPTB),
even among women in high‑burden settings.[2]
The widely held belief that FGTB is a rare site for EPTB[3,4]
is due to the challenges of limited health‑care utilization
by women, covert symptoms, and paucibacillary nature of
FGTB. The focus of national tuberculosis control programs on
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pulmonary tuberculosis (PTB) exacerbates this underestimation
of prevalence. However, among women presenting with pelvic
inflammatory disease (PID) and/or infertility, published
data from high tuberculosis burden settings indicate a high
prevalence of FGTB.[5]
Data from the 2016 national survey of tuberculosis control
program health‑care facilities in Pakistan indicate that rates of
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EPTB are higher among females as compared to males,[6] as
has also been observed in studies from South Asia.[7] However,
tuberculosis control program data are not disaggregated by the
site of EPTB and sex‑disaggregated data on incidence cannot
be used to estimate FGTB burden.
In an effort to better define the FGTB epidemiology in the
high‑burden country of Pakistan, we examined data from a
referral laboratory to report culture‑confirmed FGTB rates
among females evaluated for tuberculosis. These data are
important to inform the need for guideline development,
facilitated referral for improved health‑care delivery and
quality of life in women, physicians training, and further
research in diagnostics.

Method
Setting

We report on data from Pakistan, a high‑burden country
with an incidence of tuberculosis of 263 per 100,000
population,[8] 41% of total cases occurring in women. This
study was performed at the Aga Khan University Clinical
Laboratories, with collection outlets in 289 different locations
across Pakistan. Samples were collected in accordance with
laboratory policies and transported within 48 h to the central
mycobacteriology laboratory in Karachi, a biosafety level 3
facility. The laboratory has been accredited by the College of
American Pathologists (CAP) since 2016 and is compliant with
their standards. Laboratory records are archived for 2 years.
However, electronic patient investigation records of essential
variables are archived on a separate server at the Aga Khan
University Information Technology Unit.

Study design and data sources

This was a retrospective descriptive analysis of FGTB rates among
culture‑confirmed EPTB cases among females, with an analysis
of FGTB cases based on information obtained through linked
electronic records. Data were retrieved for the years of 2007–2016.
Supplementary Figure 1 describes data retrieval, abstraction, and
secondary database creation stages and sequence. Laboratory
records disaggregated by sex from 2007 to 2016 were retrieved,
and duplicates were removed to generate denominators for the
rates calculated for male versus female cultures requested and
the proportion of positive cultures. A second database with
culture results was retrieved from 2007 to 2016, and other
variables in the database included sex, age, specimen type,
cultured isolate identification (Mycobacterium tuberculosis or
nontuberculous mycobacteria), susceptibility testing results,
dates of specimen collection, and reporting. Linked laboratory
identifiers allowed retrieval of histopathology requisitions and
results, and linked hospital identifiers allowed examination of
patient management details, where available.
We used the ISPOR[9] and STROBE[10] checklists to evaluate
the standard of reporting for this descriptive analysis. An
intersection of both checklists for this analysis is available in
Supplementary Table 1.

Laboratory methods

From 2007 to 2016, the laboratory used both liquid and solid
media on specimens processed with 2% sodium hydroxide and
N‑acetyl‑L‑cysteine method and high‑speed centrifugation.
Extrapulmonary specimens (except cerebrospinal fluid)
were decontaminated and liquid cultures were continuously
monitored for evidence of growth for 6 weeks. The laboratory
subscribed to proficiency testing program by CAP during
the study period and obtained satisfactory results. Culture
contamination rates during the 10‑year study period remained
within the recommended benchmark of 5%–8%.[11]

Data abstraction and analysis

Data downloaded from laboratory servers were extracted
from records using a preexisting coding manual for laboratory
variables and by date (year). After initial extraction, data were
abstracted into a separate Excel database by creating drop‑down
categories for the following variables: year, sex, specimen types,
cultured isolated identification, and drug susceptibility (sensitive
or resistant) for rifampin, isoniazid, and ofloxacin. Duplicate
entries for specimen type and patient identification numbers
were removed in batches. Data quality checks and verification
were performed by comparison to source data. Any conflicts
were resolved by consultation with the author group. Data
were refined by type of FGTB specimen source, including
endometrial tissue, endometrial curettage sample, tubo‑ovarian
samples, ovarian fluid/pus/tissue, and endocervical sample.
For culture‑confirmed FGTB samples, linked histopathology
records were retrieved from the laboratory database and linked
radiology and clinical records were retrieved from the hospital
databases and a final relational database was created in MS Excel
for the culture‑confirmed FGTB cases. Frequencies and means
or median values were calculated in MS Excel and Chi‑square
test for proportions was performed where applicable using
Chi‑square test calculator from www.socstatistics.com (https://
www.socscistatistics.com/tests/chisquare2/default2.aspx).

Ethical approval

The study was reviewed and exempted from individual
informed consent by the Ethical Review Committee of the
Aga Khan University, Pakistan.

Results
Study population and laboratory utilization

From 2007 to 2016, the study laboratory received
410,748 specimens for mycobacterial culture. The male:
female ratio of all requests was 1.3. During the 10 study
years, the mean culture positivity rate was 5.9% ± 3.5%, with
2.8% ± 0.8% of these positive cultures from females of all age
groups. Data are presented in Supplementary Figure 2 to show
the variance across years.

Culture positivity and extrapulmonary tuberculosis rates
among females

Among a total of 177,463 cultures from females, 11,544 (6.5%)
were positive for M. tuberculosis complex (MTB), and
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1889 (16.4%) of these positive cultures were from
extrapulmonary specimen sources. Rifampin resistance (RR)
was observed more frequently in PTB in females at
47.5% (n = 4583), while it remained low in EPTB cases
in females at 15.8% (n = 298) (P < 0.0001; Chi‑square).
FGTB was responsible for 1.8% of all culture‑positive EPTB
specimens in females. Figure 1 shows cultures received,
positivity rates, and RR among PTB and EPTB in females of
all age groups.

Culture‑confirmed female genital tuberculosis

A total of 36 FGTB specimens were culture positive for
Mycobacterium species. Two of these samples were excluded
from this analysis due to growth of nontuberculous mycobacteria.
Of the 34 MTB culture‑positive specimens in 32 patients (two
tubo‑ovarian and one endometrial specimens were received
from one patient), 31 were females 15–49 years, with a median
age of 26.5 (32–25) years. Clinical indications, age, and linked
specimen positivity details are presented in Table 1.
Among culture‑confirmed FGTB, infertility was the most
common indication for evaluation. Only one patient had a
positive smear for acid‑fast bacilli. Molecular tests (i.e., Xpert
MTB/RIF or a nucleic acid amplification test) were not requested
on any of the patients. Histopathological details were available
in 28 patients, with 22 (78.6%) showing agreement with culture
confirmation, i.e., histopathological examination showed chronic
granulomatous inflammation with epithelioid cells and giant
cells with or without caseous necrosis. RR was observed in
3 patients in endometrial specimens. Of the two RR patients,
histopathological examination was available in two and did
not show chronic granulomatous inflammation. One patient
had a benign late secretory endometrium while the second had
abnormal secretory endometrium, with no signs of inflammation.

The low proportion of culture‑confirmed tuberculosis
observed in our data, despite the expected high prevalence
of FGTB, may be a function of any of the following
factors: paucibacillary nature and low culture yield of
genital specimens (endometrium), lack of availability or
reduced utilization of molecular methods with presumed
higher sensitivity,[14] use of private laboratory services with
data that are not captured by national programs or in this
study, or lack of access to health‑care services required
for the appropriate diagnosis and management of FGTB.
Each of these factors likely contributes to the traditional
understanding of FGTB as a “rare” form of tuberculosis in
women even in high‑burden settings. A recent evaluation
of EPTB in Pakistan for the year 2016 in public health‑care
facilities notifying tuberculosis to national authorities,
however, reveals that data are either not segregated by source
or the proportion of genitourinary specimens submitted
for women was very low,[6] again pointing to low service
utilization. Moreover, tuberculosis notification rates were
based on smear positivity and/or Xpert MTB RIF (which is
available in 5.6% of reporting facilities) and not culture or
histopathological diagnosis.[6]
The data presented demonstrate good agreement between
histopathological diagnosis of FGTB and culture positivity.
Two cases where RR MTB were cultured were not confirmed
on histopathology and may well be representative of sample
contamination during collection and transport or laboratory
cross‑contamination. Lower rates of RR among EPTB cases
in Pakistan also support the hypothesis that culture results are
a result of contamination rather than RR FGTB.[16]
The data highlight the need for improving FGTB algorithms
to facilitate improved diagnosis and management in Pakistan.
Development of new and improved diagnostic tools and

Discussion
FGTB accounts for a small proportion (1.8%) of culture‑positive
EPTB in this countrywide laboratory network. This proportion,
however, is not indicative of the incidence or prevalence
of FGTB. Data from evaluation cohorts among women of
reproductive age with infertility and PID in Pakistan have
reported higher rates of FGTB (3%–3.5%).[12,13] Furthermore,
when performed in subsets of women with infertility or
associated symptoms, the yield of laparoscopic diagnosis
is 44%, and of mycobacterial culture and/or nucleic acid,
detection by polymerase chain reaction‑based tests is 10%,[14]
and the two approaches are complementary. Laparoscopic
diagnosis of tuberculosis among women with chronic pelvic
pain from Pakistan has also demonstrated higher rates (20%),
but the laparoscopic diagnosis was not confirmed on culture
or histopathological examination of endometrial tissue.[15]
An integrated approach to diagnosis of FGTB is therefore
recommended, with availability of all these services as part of
national tuberculosis control programs in liaison with health
services for women. Particularly, Xpert Ultra may be a useful
tool in improving the yield of molecular diagnosis.
68

Figure 1: Culture‑confirmed tuberculosis among females in Pakistan
based on data from a large laboratory network 2007–2016. Figures
in the table represent total numbers of culture‑positive specimens.
MTB: Mycobacterium tuberculosis complex, RR: Rifampin‑resistant
tuberculosis, PTB: Pulmonary tuberculosis, EPTB: Extrapulmonary
tuberculosis, FGTB: Female genital tuberculosis
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Table 1: Demographics, clinical indications, and microbiological and histopathological details of 32 women with
culture‑confirmed female genital tuberculosis diagnosed at a countrywide laboratory network, 2007‑2016
Clinical indication

Age

Source

City

Year

23
23
25
25
30
27
28
34
27
26
41
26
30
35
31
25
26
22
34
30
30
17
52
25
32
15
24
25
26
35

E
E
E
E
E
E
E
E
E
E
E
E
E
E
TO
TO
E
PA
C
E
TO
TO
E
TO + E
E
E
E
E
E
E

Karachi
Karachi
Karachi
Peshawar
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Quetta
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Mianwali
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi
Karachi

2008
2009
2009
2010
2010
2012
2013
2007
2009
2010
2010
2011
2014
2014
2007
2016
2007
2009
2008
2015
2010
2014
2015
2009
2009
2011
2011
2011
2013
2010

Microbiological
Smear

Infertility

‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
+
‑
‑
‑
‑
‑

Culture

Rifampin

Chronic granulomatous inflammation
Chronic granulomatous inflammation
Chronic granulomatous inflammation
Benign late secretory endometrium
Chronic granulomatous inflammation
NA
Normal endometrial tissue
Normal endometrial tissue
Chronic granulomatous inflammation and necrosis
Normal endometrial tissue
Benign endometrial epithelium
Chronic granulomatous inflammation
Chronic granulomatous inflammation and necrosis
Chronic granulomatous inflammation and necrosis
Chronic granulomatous inflammation
Chronic granulomatous inflammation and necrosis
Menstrual irregularities/
Benign endometrial epithelium
amenorrhea
Chronic granulomatous inflammation
Postcoital bleeding
Cervical polyp, chronic nonspecific inflammation
Abdominal pain
Chronic granulomatous inflammation
Chronic granulomatous inflammation
Chronic granulomatous inflammation
Chronic granulomatous inflammation
Ectopic pregnancy
Endometrium: Chronic granulomatous inflammation
Unknown
NA
Chronic granulomatous inflammation
NA
Chronic granulomatous inflammation with necrosis
NA
Abnormal secretory endometrium with glandular
and stromal breakdown
26
E
Karachi
2014
‑
MTB
S
Chronic granulomatous inflammation
45
E
Abbottabad 2012
‑
MTB
S
Chronic granulomatous inflammation
E: Endometrium, TO: Tubo‑ovarian, C: Cervical, PA: Pelvic adhesions, MTB: Mycobacterium tuberculosis complex, NA: Not available, R: Resistant,
S: Susceptible

their application to diagnosis of FGTB should be advocated
to improve case detection and confidence in diagnosis.[17]
Implementation of these diagnostic modalities would require
strategies to improve access and service delivery to impact the
health of women through reducing FGTB in Pakistan. Lack of
published data on etiology of PID, especially granulomatous
endometritis in Pakistan, also highlights the need for research
to evaluate appropriate and innovative methods for specimen
collection and integrated diagnosis.
HIV status of women was not known and linked laboratory
and hospital databases for the 32 women with FGTB did
not reveal if any of them had been evaluated for diabetes or
prediabetes. Some limitations of this study which stem from
the study design are important to note. The retrospective
nature of the study did not allow us to address the proportion
of FGTB among all women of reproductive age group who

MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB
MTB

Histopathological
S
S
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
S
S
S
R

were evaluated for gynecological complaints. Specimen
source‑wise negative cultures could not be extracted from the
laboratory’s electronic database. We were also unable to access
an independent database of histopathological examinations
to evaluate the culture‑negative proportion of granulomatous
endometritis and salpingitis. Limitations of this study noted
above highlight the need for program linkages and electronic
databases.
Improved surveillance for FGTB paired with uptake of
complementary and enhanced diagnostic methods in women
is needed in Pakistan. Neither Xpert nor histopathology
services are widely available to allow improved diagnosis
which highlights the need for facilitated referral. The low
positivity rates of culture in FGTB should lead to advocacy
for research into and implementation of improved diagnostic
methods and strategies.

International Journal of Mycobacteriology ¦ Volume 10 ¦ Issue 1 ¦ January-March 2021

69

[Downloaded free from http://www.ijmyco.org on Friday, April 9, 2021, IP: 221.132.113.70]
Fatima, et al.: Female Genital Tuberculosis in Pakistan
7.

Ethical clearance

The study was reviewed and exempted from individual
informed consent by the Ethical Review Committee of the
Aga Khan University, Pakistan.

Financial support and sponsorship
Nil.

There are no conflicts of interest.

11.

References
2.
3.
4.
5.
6.

70

9.
10.

Conflicts of interest

1.

8.

Botha MH, van der Merwe FH. Female genital tuberculosis. S Afr Fam
Pract 2008;50:12‑6.
Goel G, Khatuja R, Radhakrishnan G, Agarwal R, Agarwal S, Kaur I.
Role of newer methods of diagnosing genital tuberculosis in infertile
women. Indian J Pathol Microbiol 2013;56:155‑7.
Ilmer M, Bergauer F, Friese K, Mylonas I. Genital tuberculosis as the
cause of tuboovarian abscess in an immunosuppressed patient. Infect
Dis Obstet Gynecol 2009;2009:745060.
Chowdhury NN. Overview of tuberculosis of the female genital tract.
J Indian Med Assoc 1996;94:345‑6,361.
Grace GA, Devaleenal DB, Natrajan M. Genital tuberculosis in females.
Indian J Med Res 2017;145:425‑36.
Tahseen S, Khanzada FM, Baloch AQ, Abbas Q, Bhutto MM,
Alizai AW, et al. Extrapulmonary tuberculosis in Pakistan – A
nation‑wide multicenter retrospective study. PLoS One
2020;15:e0232134.

12.
13.
14.
15.
16.

17.

Mehraj J, Khan ZY, Saeed DK, Shakoor S, Hasan R. Extrapulmonary
tuberculosis among females in South Asia‑gap analysis. Int J
Mycobacteriol 2016;5:392‑9.
Global tuberculosis report 2020. Geneva: World Health Organization;
2020. Licence: CC BY-NC-SA 3.0 IGO.
Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D,
et al. A checklist for retrospective database studies‑‑report of the ISPOR
Task Force on Retrospective Databases. Value Health 2003;6:90‑7.
STROBE Strengthening the Reporting of Observational Studies in
Epidemiology. University of Bern © ISPM 2009. Available from:
https://www.strobe‑statement.org/.[Last accessed December 2020 20].
CLSI. Laboratory Detection and Identification of Mycobacteria. 2nd ed.
CLSI Guideline M48. Wayne PA: Clinical and Laboratory Standards
Institute; 2018.
Shaheen R, Subhan F, Tahir F. Epidemiology of genital tuberculosis in
infertile population. J Pak Med Assoc 2006;56:306‑9.
Haider P, Jafarey SN. A histopathological study of endometrial
tuberculosis in infertility. J Pak Med Assoc 1992;42:269‑71.
Jindal UN, Bala Y, Sodhi S, Verma S, Jindal S. Female genital
tuberculosis: Early diagnosis by laparoscopy and endometrial
polymerase chain reaction. Int J Tuberc Lung Dis 2010;14:1629‑34.
Baloch S, Khaskheli MN, Malik AM. Diagnostic laparoscopic findings
in chronic pelvic pain. J Coll Physicians Surg Pak 2013;23:190‑3.
Tahseen S, Ambreen A, Masood F, Qadir M, Hussain A, Jamil M,
et al. Primary drug resistance in extra‑pulmonary tuberculosis:
A hospital‑based prospective study from Pakistan. Int J Tuberc Lung
Dis 2019;23:900‑6.
Munne KR, Tandon D, Chauhan SL, Patil AD. Female genital
tuberculosis in light of newer laboratory tests: A narrative review. Indian
J Tuberc 2020;67:112‑20.

International Journal of Mycobacteriology ¦ Volume 10 ¦ Issue 1 ¦ January-March 2021

